Keyphrases
APOBEC3B
90%
Cervical Cancer
7%
Cervix
7%
Cetuximab
16%
Community Health Needs
45%
Community Relevance
45%
Cultural Relevance
45%
Degree of Differentiation
8%
DNA Cytosine Deaminase
7%
DNA Deaminase
90%
E6 Oncoprotein
7%
E6 Protein
18%
Expression Activity
7%
Formalin-fixed Paraffin-embedded Tissue
8%
Frozen Tissue
8%
Functional Inactivation
15%
G2-M Cell Cycle Arrest
9%
Genomic Uracil
7%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
90%
High-risk HPV
90%
HPV DNA
90%
HPV Negative
9%
HPV Oncogenes
29%
HPV Positive
90%
HPV16
90%
HPV16 E7
36%
HPV18
72%
HPV31
36%
Human Papillomavirus DNA
18%
Human Papillomavirus Negative
7%
Human Tumor Viruses
29%
In Vitro Model System
29%
Intrinsic Radiation Sensitivity
9%
Mutation Bias
7%
Mutator Phenotype
7%
Newly Diagnosed
8%
Nutrient Impact
45%
Oral Epithelial Cells
29%
Oral Keratinocytes
90%
P16 Staining
8%
Papillomavirus Infections
7%
Passage Cells
16%
Project Execution
45%
Radiation Exposure
9%
Radiation Resistance
9%
Rapid Test
8%
Response to Cancer Therapy
8%
Spearman Correlation
8%
Stratified Epithelium
60%
Stratified Squamous
29%
Support Mechanisms
9%
Tonsillar
9%
Tumor Differentiation
8%
Tumor Marker
8%
Tumorgraft
90%
Upper Aerodigestive Tract
29%
Viral Maintenance
90%
Immunology and Microbiology
Antiviral Activity
11%
Cell Line
11%
Cell Strain
45%
Cetuximab
29%
Enzyme Activity
11%
Flushing
15%
Genetic Transcription
11%
Genetic Transfection
11%
Head and Neck Cancer Cell Line
19%
Human Papillomavirus Type 16
70%
Human Papillomavirus Type 18
39%
Human Papillomavirus Type 31
19%
Innate Immune System
11%
Mutagenesis
11%
Neck
33%
Oncovirus
11%
Ovary
11%
Radioresistance
90%
Upregulation
90%
Wart Virus
100%
Medicine and Dentistry
Cell Cycle Arrest
9%
Cell Strain
45%
Cetuximab
29%
Head and Neck Cancer Cell Line
19%
Head and Neck Squamous Cell Carcinoma
90%
Human Papillomavirus Type 16
9%
Microfold Cell
9%
P16
29%
Radiation Exposure
9%
Radiosensitivity
90%
Rapid Test
15%
Tumor Marker
15%
